Dear Doctor Letter (Rote-Hand-Brief) on VOLIBRIS® (ambrisentan): New Contraindication
2012.07.09
Active substance: ambrisentan
VOLIBRIS® (ambrisentan) must not be given to patients with idiopathic pulmonary fibrosis (IPF).
Download DHPC / Information letter , Download_VeroeffentlichtAm_EN